Suchergebnisse - "Sarilumab"

PubPharm (188)

1

Sarilumab (Kevzara) for polymyalgia rheumatica

enthalten in: The Medical letter on drugs and therapeutics | 2024

2

A double-blind, placebo-controlled, randomized withdrawal trial of sarilumab for the treatment of glucocorticoid-dependent sarcoidosis

enthalten in: Rheumatology (Oxford, England) | 2024

von Baker, M. | Horomanski, A. | Wang, Y. | +7

3

Effectiveness and safety of sarilumab in patients with rheumatoid arthritis : A multicenter, retrospective, inverse probability of treatment-weighted analysis based on the FRAB-registry

enthalten in: Clinical rheumatology | 2024

von Harada, H. | Kondo, M. | Maeyama, A. | +8

ErratumIn: Clin Rheumatol. 2024 Mar 15;:. - PMID 38489137

4

Safety and effectiveness of sarilumab in Japanese patients with rheumatoid arthritis refractory to previous treatments : An interim analysis of a post-marketing surveillance

enthalten in: Modern rheumatology | 2024

von Kameda, H. | Tasaka, S. | Takahashi, T. | +3

5

Cancer risk with tocilizumab/sarilumab, abatacept, and rituximab treatment in patients with rheumatoid arthritis : a Danish cohort study

enthalten in: Rheumatology (Oxford, England) | 2024

von Westermann, R. | Cordtz, R. | Duch, K. | +4

6

Sarilumab for polymyalgia rheumatica

enthalten in: Zeitschrift fur Rheumatologie | 2024

von Schmidt, W.

7

Comparison of the efficacy and safety of tocilizumab, sarilumab, and olokizumab in patients with active rheumatoid arthritis : a network meta-analysis of randomized controlled trials

enthalten in: Zeitschrift fur Rheumatologie | 2024

von Ho Lee, Y. | Gyu Song, G.

8

Risk factors for thromboembolic events in patients hospitalized for COVID-19 pneumonia in a general ward and requiring treatment with oxygen

enthalten in: Postgraduate medical journal | 2024

von Degrave, R. | Murris, J. | Charles-Nelson, A. | +10

9

Effect of Anti-Interleukin-6 Agents on Psychopathology in a Sample of Patients with Post-COVID-19 Syndrome : An Observational Study

enthalten in: Brain sciences | 2024

von Simonetti, A. | Restaino, A. | Bernardi, E. | +10

10

Anti-GM-CSF otilimab versus sarilumab or placebo in patients with rheumatoid arthritis and inadequate response to targeted therapies : a phase III randomised trial (contRAst 3)

enthalten in: Annals of the rheumatic diseases | 2023

von Taylor, P. | Weinblatt, M. | McInnes, I. | +18

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[19]